Oscillating magnet array-based nanomagnetic gene transfection of human mesenchymal stem cells

Nanomedicine

Volumn 9, Issue 7, 2014, Pages 989-997

  Fouriki, Angeliki ^a   Dobson, Jon ^a,b  

^a KEELE UNIVERSITY   (United Kingdom)

^b University of Florida   (United States)

Author keywords

magnetic field; magnetic nanoparticle; nanomagnetic gene transfection; nonviral gene transfection

Indexed keywords

BORON; CELL SURFACE MARKER; DNA; GREEN FLUORESCENT PROTEIN; IRON; MAGNETIC NANOPARTICLE; NEODYMIUM; MAGNETITE NANOPARTICLE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA BINDING; ENDOCYTOSIS; ENDOSOME; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAGNET; MAGNETIC FIELD; MECHANICAL STIMULATION; MESENCHYMAL STEM CELL; OSCILLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; CHEMISTRY; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PROCEDURES;

GREEN FLUORESCENT PROTEINS; HUMANS; MAGNETITE NANOPARTICLES; MESENCHYMAL STROMAL CELLS; TRANSFECTION;

EID: 84903851643     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.74     Document Type: Article

References (34)

1. Cho HJ, Lee TS, Park JB et al. Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J. Biochem. Mol. Biol. 40, 1069-1076 (2007).
2. Kersting C, Gebert C, Agelopoulos K et al. Epidermal growth factor receptor expression in high-grade osteosarcoma is associated with a good clinical outcome. Clin. Cancer Res. 13, 2998-3005 (2007). (Pubitemid 46849576)
3. Lamoureux F, Richard P, Wittrant Y et al. Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockage of the vicious cycle between tumor cell proliferation and bone resorption. Cancer Res. 67, 7308-7318 (2007). (Pubitemid 47206560)
4. Nguyen LT, Atobe K, Barichello JM et al. Complex formation with plasmid DNA increases the cytotoxicity of cationic liposomes. Biol. Pharm. Bull. 30, 751-757 (2007). (Pubitemid 46571005)
5. Park JS, Na K, Woo DG et al. Non-viral gene delivery of DNA polyplexed with nanoparticles transfected into human mesenchymal stem cells. Biomaterials 31, 124-132 (2012).
6. Lai Y, Drobinskaya I, Kolossov E et al. Genetic modification of cells for transplantation. Adv. Drug Deliv. Rev. 60, 146-159 (2008). (Pubitemid 350236396)
7. Lu Y. Viral based gene therapy for prostate cancer. Curr. Gene Ther. 1, 183-200 (2001).
8. Bhattarai SR, Kim SY, Jang KY et al. Laboratory formulated magnetic nanoparticles for enhancement of viral gene expression in suspension cell line. J. Virol. Methods 147, 213-218 (2008).
9. Verma IM. A tumultuous year for gene therapy. Mol. Ther. 2, 415-416 (2000).
10. Spack EG, Corgi FL. Developing non-viral DNA delivery systems for cancer and infectious disease. Drug Disc. Today 6, 186-197 (2001). (Pubitemid 32118191)
11. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem. Rev. 109, 259-302 (2009).
12. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147 (1999). (Pubitemid 29282067)
13. Chamberlain G, Fox J, Ashton B et al. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features and potential for homing. Stem Cells 25, 2739-2749 (2007). (Pubitemid 350127858)
14. Chen Y, Shao JZ, Xiang LX et al. Mesenchymal stem cells: a promising candidate in regenerative medicine. Int. J. Biochem. Cell Biol. 40, 815-820 (2008).
15. Schop D, Dijkhuizen-Radersma R, Borgart E et al. Expansion of human mesenchymal stromal cells on microcarriers: growth and metabolism. J. Tissue Eng. Regen. Med. 4, 131-140 (2009).
16. Mah C, Zolotukhin I, Fraites TJ et al. Microsphere-mediated delivery of recombinant AVV vectors in vitro and in vivo. Mol. Ther. 1, S239 (2000).
17. Mah C, Fraites TJ, Zolotukhin I et al. Improved method of recombinant AAV2 delivery for systemic targeted gene delivery. Mol. Ther. 6, 106-112 (2002). (Pubitemid 36124277)
18. Scherer F, Anton M, Schillinger U et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9, 102-109 (2002). (Pubitemid 34189525)
19. Plank C, Schillinger U, Scherer F et al. The magnetofection method: using magnetic force to enhance gene delivery. Biol. Chem. 384, 737-747 (2003). (Pubitemid 36747935)
20. Krotz F, Sohn HY, Gloe T et al. Magnetofection potentiates gene delivery to cultured endothelial cells. J. Vasc. Res. 40, 425-434 (2003).
21. Dobson J. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther. 13, 283-287 (2006). (Pubitemid 43223096)
22. Muthana M, Scott SD, Farrow N et al. A novel magnetic approach to enhance the efficacy of cell-based gene therapies. Gene Ther. 15, 902-910 (2008).
23. McBain SC, Griesenbach U, Xenariou S et al. Magnetic nanoparticles as gene delivery agents: enhanced transfection in the presence of oscillating magnet arrays. Nanotechnol. 19, 405102 (2008).
24. Pickard M, Chari D. Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by 'magnetofection': effects of static and oscillating fields. Nanomedicine 5, 217-232 (2012).
25. Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 23, 1553-1561 (2002). (Pubitemid 34158578)
26. Dobson J. Magnetic micro and nano particle based targeting for drug and gene delivery. Nanomedicine 1, 31-37 (2006).
27. Kim SJ, Yoon TJ, Yu KN et al. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol. Sci. 89, 338-347 (2006). (Pubitemid 43013783)
28. McBain SC, Yiu HHP, Dobson J. Magnetic nanoparticles for gene and drug delivery. Int. J. Nanomedicine 3, 169-180 (2008).
29. Fouriki A, Clements MA, Farrow N et al. Efficient transfection of mg-63 osteoblasts using magnetic nanoparticles and oscillating magnet arrays. J. Tissue Eng. Regen. Med. doi:10.1002/term.1508 (2012) (Epub ahead of print).
30. Furlani EP, Xue X. A model for predicting field-directed particle transport in the magnetofection process. Pharm. Res. 29(5), 1366-1379 (2012).
31. Furlani EP, Xue X. Field, force and transport analysis for magnetic particle-based gene delivery. Microfluidics Nanofluidics 13(4), 589-602 (2012).
32. Lim J, Dobson J. Improved transfection of HUVEC and MEF cells using DNA complexes with magnetic nanoparticles in an oscillating field. J. Genet. 91(2), 223-227 (2012).
33. Midoux P, Pichon C, Yaouanc JJ et al. Chemical vectors for gene delivery: a current review on polymers, peptides, and lipids containing histidine or imidazole as nucleic acids carriers. Br. J. Pharmacol. 157, 166-178 (2009).
34. Fouriki A, Farrow N, Clements M et al. Evaluation of the magnetic field requirements for nanomagnetic gene transfection. Nano Rev. doi:10.3402/nano. v1i0.5167 (2010) (Epub ahead of print).